Important recall notice: Ranitidine recall – Sandoz Inc.

30 de Octubre del 2019

On September 23, 2019, Sandoz, Inc. announced issued a voluntary recall of all lots of Ranitidine capsules due to an elevated amount of an unexpected impurity (NDMA) found in the active pharmaceutical ingredient.

Express Scripts will mail letters to patients who have received medication impacted by the recall.

The FDA recommends speaking with your prescriber if you want to stop your medication or use an alternative medication.

Product Name

NDC Number

Lot Nbr.

Expiration Date

Date of Manufacture

RANITIDINE 150mg Capsules 500 count

0781-2855-05

HD1862

04/30/2020

04/19/2017

RANITIDINE 150mg Capsules 500 count

0781-2855-05

HP9438

09/30/2020

09/05/2017

RANITIDINE 150mg Capsules 500 count

0781-2855-05

HP9439

09/30/2020

09/06/2017

RANITIDINE 150mg Capsules 500 count

0781-2855-05

HP9440

09/30/2020

09/05/2017

RANITIDINE 150mg Capsules 60 count

0781-2855-60

HC9266

04/30/2020

04/19/2017

RANITIDINE 150mg Capsules 60 count

0781-2855-60

HD1865

04/30/2020

04/19/2017

RANITIDINE 150mg Capsules 60 count

0781-2855-60

HP9441

09/30/2020

09/06/2017

RANITIDINE 150mg Capsules 60 count

0781-2855-60

JK7994

08/31/2021

08/07/2018

RANITIDINE 150mg Capsules 60 count

0781-2855-60

JK8659

08/31/2021

08/07/2018

RANITIDINE 300mg Capsules 30 count

0781-2865-31

HD8625

04/30/2020

04/27/2017

RANITIDINE 300mg Capsules 30 count

0781-2865-31

HD9275

04/30/2020

04/27/2017

RANITIDINE 300mg Capsules 30 count

0781-2865-31

HU2207

08/31/2020

08/24/2017

RANITIDINE 300mg Capsules 30 count

0781-2865-31

HX6676

03/31/2021

03/20/2018

RANITIDINE 300mg Capsules 30 count

0781-2865-31

HX6677

03/31/2021

03/20/2018

Additional information is available on the FDA’s website:

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sandoz-inc-issues-voluntary-recall-ranitidine-hydrochloride-capsules-150mg-and-300mg-due-elevated

Última actualización: 08 de Diciembre del 2023